JP2013535445A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535445A5
JP2013535445A5 JP2013520241A JP2013520241A JP2013535445A5 JP 2013535445 A5 JP2013535445 A5 JP 2013535445A5 JP 2013520241 A JP2013520241 A JP 2013520241A JP 2013520241 A JP2013520241 A JP 2013520241A JP 2013535445 A5 JP2013535445 A5 JP 2013535445A5
Authority
JP
Japan
Prior art keywords
activation
antibody against
pharmaceutical composition
enhancing antibody
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013520241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535445A (ja
Filing date
Publication date
Priority claimed from RU2010130353/15A external-priority patent/RU2542445C2/ru
Priority claimed from RU2011127058/15A external-priority patent/RU2536232C2/ru
Application filed filed Critical
Priority claimed from PCT/IB2011/002434 external-priority patent/WO2012010978A2/en
Publication of JP2013535445A publication Critical patent/JP2013535445A/ja
Publication of JP2013535445A5 publication Critical patent/JP2013535445A5/ja
Pending legal-status Critical Current

Links

JP2013520241A 2010-07-21 2011-07-15 アルツハイマー病を治療する方法 Pending JP2013535445A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
RU2010130353 2010-07-21
RU2010130353/15A RU2542445C2 (ru) 2010-07-21 2010-07-21 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2011127058/15A RU2536232C2 (ru) 2011-07-01 2011-07-01 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2011127058 2011-07-01
PCT/IB2011/002434 WO2012010978A2 (en) 2010-07-21 2011-07-15 A method of treating alzheimer's disease

Publications (2)

Publication Number Publication Date
JP2013535445A JP2013535445A (ja) 2013-09-12
JP2013535445A5 true JP2013535445A5 (OSRAM) 2014-04-24

Family

ID=44863153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013520241A Pending JP2013535445A (ja) 2010-07-21 2011-07-15 アルツハイマー病を治療する方法

Country Status (16)

Country Link
US (1) US20130058982A1 (OSRAM)
EP (1) EP2596021A2 (OSRAM)
JP (1) JP2013535445A (OSRAM)
CN (1) CN103119060A (OSRAM)
AU (1) AU2011281252A1 (OSRAM)
CA (1) CA2805943A1 (OSRAM)
DE (1) DE112011102409T5 (OSRAM)
EA (1) EA029399B1 (OSRAM)
FR (1) FR2962912A1 (OSRAM)
GB (1) GB2496801B (OSRAM)
IT (1) ITTO20110633A1 (OSRAM)
MX (1) MX2013000808A (OSRAM)
NZ (1) NZ606969A (OSRAM)
PH (1) PH12013500143A1 (OSRAM)
UA (1) UA107836C2 (OSRAM)
WO (1) WO2012010978A2 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
CA2805091A1 (en) 2010-07-15 2012-01-19 Oleg Iliich Epshtein Pharmaceutical compositions comprising a homopathically potentized form of an antibody to human cannabinoid receptor
WO2012017324A2 (en) 2010-07-15 2012-02-09 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
PH12013500107A1 (en) * 2010-07-15 2013-03-11 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
PH12013500144A1 (en) 2010-07-21 2018-03-21 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
ITTO20110630A1 (it) * 2010-07-21 2012-01-22 Oleg Iliich Epshtein Composizioni farmaceutiche di combinazione e metodo per trattare vertigini, cinetosi e distonia vascolare vegetativa
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
CN104324359B (zh) * 2014-09-25 2016-08-17 中山大学 Rry三肽在制备治疗阿尔茨海默症药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2156621C1 (ru) 1999-03-04 2000-09-27 Эпштейн Олег Ильич Нейротропное лекарственное средство
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030087250A1 (en) * 2001-03-14 2003-05-08 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
US6451547B1 (en) * 2001-04-25 2002-09-17 Syn X Pharma Process for differential diagnosis of Alzheimer's dementia and device therefor
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
US20070224201A1 (en) * 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004082597A2 (en) 2003-03-14 2004-09-30 Nutrition Research, Inc. Homeopathic formulations useful for treating pain and/or inflammmation
BRPI0601496B8 (pt) * 2006-04-13 2021-05-25 Miria De Amorim composições medicamentosas, uso das mesmas, kits medicamentosos e método de aplicação das composições medicamentosas
ITTO20110630A1 (it) * 2010-07-21 2012-01-22 Oleg Iliich Epshtein Composizioni farmaceutiche di combinazione e metodo per trattare vertigini, cinetosi e distonia vascolare vegetativa

Similar Documents

Publication Publication Date Title
JP2013535445A5 (OSRAM)
JP2013536174A5 (OSRAM)
JP2013535444A5 (OSRAM)
JP2013535436A5 (OSRAM)
CY1120637T1 (el) Πολυπεπτιδικα αντισωματα που ανταγωνιζονται cd40
HK1210792A1 (en) Molecules with antigen binding and polyvalent fc gamma receptor binding activity
JP2013533268A5 (OSRAM)
JP2013537532A5 (OSRAM)
EA201190018A1 (ru) Миостатинсвязывающие белки
UA112743C2 (uk) Терапевтичний dll4-зв'язувальний білок
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
JP2013533269A5 (OSRAM)
EA201170357A1 (ru) Инженерные антитела к il-13: композиции, способы и применение
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
WO2013120012A3 (en) Cdim binding proteins and uses thereof
AR082245A1 (es) Composicion farmaceutica de combinacion para tratar enfermedades funcionales o condiciones de tracto gastrointestinal
HRP20200936T1 (hr) Antitijela za beta amiloid
CL2007003635A1 (es) Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer.
PH12013501636A1 (en) Treatment of osteoarthritis and pain
PH12012502244A1 (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
JO3462B1 (ar) أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
RU2018117862A (ru) Новый полипептид с аффинностью к PD-L1
WO2013059559A3 (en) Compounds and methods for enhancing innate immune responses
UA112755C2 (uk) Метод лікування синдрому дефіциту уваги і гіперактивності
WO2006110214A3 (en) Antibodies against mammalian metapneumovirus